Piramal Critical Care (PCC), a business division of Piramal Pharma Limited (PPL) is a leader in inhaled anesthetics and a global player in hospital generics. “Saving and improving patients’ lives” is much more than a purpose statement to us. We are motivated by our vision of commitment to delivering critical care solutions for patients and healthcare providers, while achieving sustainable and profitable growth for all the stakeholders. Piramal Critical Care maintains a wide presence across the US, Europe and more than 100 countries across the globe. Our product portfolio includes inhalation anesthetics, intrathecal therapy for spasticity management, injectable pain and anesthesia drugs, injectable anti-infectives, oral therapy for Type I Gaucher and Niemann pick Type C disease, anticholinergic, plasma volume expander, non-depolarizing neuromuscular blocking agent, depolarizing skeletal muscle relaxant and an anxiolytic, sedative and pain medication.
PCC has strong manufacturing and process development experience. PCC has fully owned manufacturing facilities in Bethlehem, PA, USA and Digwal, India. Customer centricity is the cornerstone of our business.
*RTU Ready to use
Please note that adverse effects for any of our products should be reported to: medical.information@piramal.com
-
Industry
-
Pharmaceutical Manufacturing
-
Company size
-
201-500 employees
-
Headquarters
-
Bethlehem, Pennsylvania
-
Type
-
Privately Held